|
1
|
Huang J, Jiang W, Xu R, Huang H, Lv Y, Xia
Z, Sun X, Guan Z, Lin T and Li Z: Primary gastric non-Hodgkin's
lymphoma in Chinese patients: Clinical characteristics and
prognostic factors. BMC Cancer. 10:3582010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Psyrri A, Papageorgiou S and Economopoulos
T: Primary extranodal lymphomas of stomach: Clinical presentation,
diagnostic pitfalls and management. Ann Oncol. 19:1992–1999. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakamura S, Matsumoto T, Iida M, Yao T and
Tsuneyoshi M: Primary gastrointestinal lymphoma in Japan: A
clinicopathologic analysis of 455 patients with special reference
to its time trends. Cancer. 97:2462–2473. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
D'Amore F, Christensen BE, Thorling K,
Pedersen M, Jensen MK, Boesen AM, Andersen E, Johansen P and
Mortensen LS: Incidence, presenting features and prognosis of
low-grade B-cell non-Hodgkin's lymphomas. Population-based data
from a Danish lymphoma registry. Leuk Lymphoma. 12:69–77. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koch P, Probst A, Berdel WE, Willich NA,
Reinartz G, Brockmann J, Liersch R, del Valle F, Clasen H, Hirt C,
et al: Treatment results in localized primary gastric lymphoma:
Data of patients registered within the German multicenter study
(GIT NHL 02/96). J Clin Oncol. 23:7050–7059. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang F, Meng W, Wang B and Qiao L:
Helicobacter pylori-induced gastric inflammation and gastric
cancer. Cancer Lett. 345:196–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Campuzano-Maya G: Hematologic
manifestations of Helicobacter pylori infection. World J
Gastroenterol. 20:12818–12838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Konturek PC, Hartwich A, Zuchowicz M,
Labza H, Pierzchalski P, Karczewska E, Bielanski W, Hahn EG and
Konturek SJ: Helicobacter pylori, gastrin and
cyclooxygenases in gastric cancer. J Physiol Pharmacol. 51:737–749.
2000.PubMed/NCBI
|
|
9
|
Yamac D, Ayyildiz T, Coşkun U, Akyürek N,
Dursun A, Seckin S and Koybasioglu F: Cyclooxygenase-2 expression
and its association with angiogenesis, Helicobacter pylori,
and clinicopathologic characteristics of gastric carcinoma. Pathol
Res Pract. 204:527–536. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Akdis M, Burgler S, Crameri R, Eiwegger T,
Fujita H, Gomez E, Klunker S, Meyer N, O'Mahony L, Palomares O, et
al: Interleukins, from 1 to 37, and interferon-γ: receptors,
functions, and roles in diseases. J Allergy Clin Immunol.
127:701–721–e701–770. 2011. View Article : Google Scholar
|
|
11
|
Zeng Q, Li S, Zhou Y, Ou W, Cai X, Zhang
L, Huang W, Huang L and Wang Q: Interleukin-32 contributes to
invasion and metastasis of primary lung adenocarcinoma via NF-κB
induced matrix metalloproteinases 2 and 9 expression. Cytokine.
65:24–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng LS, Zhuang Y, Li WH, Zhou YY, Wang
TT, Chen N, Cheng P, Li BS, Guo H, Yang SM, et al: Elevated
interleukin-32 expression is associated with Helicobacter
pylori-related gastritis. PLoS One. 9:e882702014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gui M, Zhang H, Zhong K, Li Y, Sun J and
Wang L: Clinical significance of interleukin-32 expression in
patients with rheumatoid arthritis. Asian Pac J Allergy Immunol.
31:73–78. 2013.PubMed/NCBI
|
|
14
|
Lee S, Kim JH, Kim H, Kang JW, Kim SH,
Yang Y, Kim J, Park J, Park S, Hong J, et al: Activation of the
interleukin-32 pro-inflammatory pathway in response to human
papillomavirus infection and over-expression of interleukin-32
controls the expression of the human papillomavirus oncogene.
Immunology. 132:410–420. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li W, Liu Y, Mukhtar MM, Gong R, Pan Y,
Rasool ST, Gao Y, Kang L, Hao Q, Peng G, et al: Activation of
interleukin-32 pro-inflammatory pathway in response to influenza A
virus infection. PLoS One. 3:e19852008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lewin KJ, Ranchod M and Dorfman RF:
Lymphomas of the gastrointestinal tract: A study of 117 cases
presenting with gastrointestinal disease. Cancer. 42:693–707. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tomonaga M: Outline and direction of
revised WHO classification of Tumors of Haematopoietic and Lymphoid
Tissues. Rinsho Ketsueki. 50:1401–1406. 2009.(In Japanese).
PubMed/NCBI
|
|
18
|
Rohatiner A, d'Amore F, Coiffier B,
Crowther D, Gospodarowicz M, Isaacson P, Lister TA, Norton A, Salem
P, Shipp M, et al: Report on a workshop convened to discuss the
pathological and staging classifications of gastrointestinal tract
lymphoma. Ann Oncol. 5:397–400. 1994.PubMed/NCBI
|
|
19
|
Li Y, Li S, Sun D, Song L and Liu X:
Expression of 15-hydroxyprostaglandin dehydrogenase and
cyclooxygenase-2 in non-small cell lung cancer: Correlations with
angiogenesis and prognosis. Oncol Lett. 8:1589–1594.
2014.PubMed/NCBI
|
|
20
|
Bayerdörffer E, Neubauer A, Rudolph B,
Thiede C, Lehn N, Eidt S and Stolte M: MALT Lymphoma Study Group:
Regression of primary gastric lymphoma of mucosa-associated
lymphoid tissue type after cure of Helicobacter pylori
infection. Lancet. 345:1591–1594. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wündisch T, Thiede C, Morgner A, Dempfle
A, Günther A, Liu H, Ye H, Du MQ, Kim TD, Bayerdörffer E, et al:
Long-term follow-up of gastric MALT lymphoma after Helicobacter
pylori eradication. J Clin Oncol. 23:8018–8024. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kuo SH, Yeh KH, Wu MS, Lin CW, Hsu PN,
Wang HP, Chen LT and Cheng AL: Helicobacter pylori
eradication therapy is effective in the treatment of early-stage
H pylori-positive gastric diffuse large B-cell lymphomas.
Blood. 119:4838–4844; quiz 5057. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hazar B, Ergin M, Seyrek E, Erdoğan S,
Tuncer I and Hakverdi S: Cyclooxygenase-2 (Cox-2) expression in
lymphomas. Leuk Lymphoma. 45:1395–1399. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Paydas S, Ergin M, Seydaoglu G, Erdogan S
and Yavuz S: Prognostic (corrected) significance of
angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral
factors in 88 cases with diffuse large B cell lymphoma and review
of the literature. Leuk Res. 33:1627–1635. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wun T, McKnight H and Tuscano JM:
Increased cyclooxygenase-2 (COX-2): A potential role in the
pathogenesis of lymphoma. Leuk Res. 28:179–190. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suga H, Sugaya M, Miyagaki T, Kawaguchi M,
Fujita H, Asano Y, Tada Y, Kadono T and Sato S: The role of IL-32
in cutaneous T-cell lymphoma. J Invest Dermatol. 134:1428–1435.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miettinen A, Karttunen TJ and Alavaikko M:
Lymphocytic gastritis and Helicobacter pylori infection in
gastric lymphoma. Gut. 37:471–476. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bartchewsky W Jr, Martini MR, Masiero M,
Squassoni AC, Alvarez MC, Ladeira MS, Salvatore D, Trevisan M,
Pedrazzoli J Jr and Ribeiro ML: Effect of Helicobacter
pylori infection on IL-8, IL-1β and COX-2 expression in
patients with chronic gastritis and gastric cancer. Scand J
Gastroenterol. 44:153–161. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Denkert C, Winzer KJ, Müller BM, Weichert
W, Pest S, Köbel M, Kristiansen G, Reles A, Siegert A, Guski H, et
al: Elevated expression of cyclooxygenase-2 is a negative
prognostic factor for disease free survival and overall survival in
patients with breast carcinoma. Cancer. 97:2978–2987. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li HL, Sun BZ and Ma FC: Expression of
COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid
tissue lymphoma. World J Gastroenterol. 10:1862–1866. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kato Y, Nishihara H, Mohri H, Kanno H,
Kobayashi H, Kimura T, Tanino M, Terasaka S and Tanaka S:
Clinicopathological evaluation of cyclooxygenase-2 expression in
meningioma: Immunohistochemical analysis of 76 cases of low and
high-grade meningioma. Brain Tumor Pathol. 31:23–30. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Al-Moundhri MS, Al-Hadabi I, Al-Mawaly K,
Kumar S, Al-Lawati FA, Bhatnager G, Kuruvila S, Al-Hamdani A,
El-Sayed SM and Al-Bahrani B: Prognostic significance of
cyclooxygenase-2, epidermal growth factor receptor 1, and
microvascular density in gastric cancer. Med Oncol. 29:1739–1747.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ishigami S, Arigami T, Uchikado Y,
Setoyama T, Kita Y, Sasaki K, Okumura H, Kurahara H, Kijima Y,
Harada A, et al: IL-32 expression is an independent prognostic
marker for gastric cancer. Med Oncol. 30:4722013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Koh YW, Park C, Yoon DH, Suh C and Huh J:
Prognostic significance of COX-2 expression and correlation with
Bcl-2 and VEGF expression, microvessel density, and clinical
variables in classical Hodgkin lymphoma. Am J Surg Pathol.
37:1242–1251. 2013. View Article : Google Scholar : PubMed/NCBI
|
